Innovax – Wantai BioPharm

MOU Ceremony Between NVI, Thailand and Innovax on Co-Development of Innovax’s HPV Vaccines

Nonthaburi, Thailand – On 23rd March, 2018, Dr. Charung Muangchana, Managing Director of the National Vaccine Institute, Thailand(NVI), and Mr. Steven Gao, General Manager of Xiamen Innovax

Innovax News Articles

Relocation of INNOVAX’s Headquarters

INNOVAX announces that it will relocate its Headquarter on 18th November 2017. The new headquarters are located at 1st Floor, 50 Shan Bian Hong East Road, Haicang District, Xiamen, Fujian, China.

Innovax Scientific Articles

HPV Vaccination in China Needs to Be More Cost-Effective

Almost all cases of cervical cancer are caused by human papillomavirus (HPV). China accounts for about a third of the global burden of cervical cancer, with about 98 900 new cases of cervical

Hecolin Hepatitis E News Articles

MSF Calls on WHO to Prequalify Hepatitis E Vaccine

Médecins Sans Frontières (MSF) is calling on the World Health Organisation (WHO) and Governments to prequalify a ground-breaking vaccine for Hepatitis E, a viral disease causing more than 50,000

Hecolin Innovax News Articles

A Giant Step Forward, INNOVAX’s Hecolin^® Is Expected to Enter the Pakistani Market Early 2018!

Drug Regulatory Authority of Pakistan announced the approval of Hepatitis E vaccine, Hecolin? as per import policy for finished drugs and valid legalized COPP on July 15 this year. Dr. Huma

Innovax News Articles

PATH & Innovax Enter Collaboration to Accelerate HPV2 Supply in Developing Countries

On 30th June, 2017, PATH and Xiamen Innovax Biotech Co., Ltd (Innovax) finalized the Collaboration and Global Access agreement under which PATH will provide technical assistance to support

Hecolin Innovax News Articles

Collaboration with Icddr,b, the First International Show of the HEV Vaccine – Hecolin^®

Since 2016, Innovax have been cooperating with International Centre for Diarrhoeal Disease Research, Bangladesh(icddr,b) scientists to conduct research on a vaccine for Hepatitis E, a troubling

Hecolin Innovax Scientific Articles

Escherichia Coli-Derived Virus-Like Particles in Vaccine Development

Abstract – Recombinant virus-like particle-based vaccines are composed of viral structural proteins and mimic authentic native viruses but are devoid of viral genetic materials. They are

Innovax News Articles

Continued: IVI and Innovax Launch Efforts to Make World’s First Hepatitis E Vaccine Available for Global Public Health

Xiamen,China – On first and second day of November of this year, the final meeting for assessment of Hepatitis E vaccine was held smoothly at INNOVAX. The outcome from the assessment was

Innovax News Articles

Mr. Steven Gao Elected as the DCVMN Executive Committee Member for the Fourth Consecutive Time

The general manager of INNOVAX – Mr. Steven Gao was elected to the new executive committee in the DCVMN Annual Meeting in Buenos Aires, Argentina, 26 Oct 2016. A total of seven executive